PEMF and PEC Blocks in Mastectomy Reconstruction Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

March 7, 2022

Study Completion Date

March 7, 2022

Conditions
Breast Cancer Female
Interventions
DRUG

Bupivacaine Hydrochloride

For active drug, 0.25% marcaine, will be used.

OTHER

Placebo Drug

For sham drug, 0.9% saline, will be used.

DEVICE

Pulsed Electromagnetic Field (PEMF) Device

The pulsed electromagnetic field signal will consist of a 2-m sec burst of 27.12 megahertz (MHz) radiofrequency sinusoidal waves repeating at 2 bursts/second.

OTHER

Placebo Device

Sham devices will appear identical to and will be used in exactly the same manner as active devices but will produce no electromagnetic field.

DRUG

Ropivacaine Hydrochloride

For active drug, 0.25% naropin, will be used.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03360214 - PEMF and PEC Blocks in Mastectomy Reconstruction Patients | Biotech Hunter | Biotech Hunter